Philip Morris International Inc.'s Stock Analysis

Philip Morris International Increases Quarterly Dividend by 8.9%

On September 19, 2025, Philip Morris International Inc. announced an increase in its regular quarterly dividend by 8.9%, raising it to $1.47 per share, which equates to an annualized rate of $5.88 per share. This dividend will be payable on October 20, 2025, to shareholders on record as of October 3, 2025, with the ex-dividend date also set for October 3, 2025. Since becoming a public company in 2008, the company has consistently raised its annual dividend, totaling a 219.6% increase over that period, representing a compound annual growth rate of 7.1%. 

Philip Morris International continues to evolve its product portfolio towards a smoke-free future, with a significant focus on smoke-free products that accounted for 41% of total net revenues in the first half of 2025. The company has invested over $14 billion since 2008 in developing smoke-free alternatives and currently offers products in 97 markets. The U.S. Food and Drug Administration has authorized marketing for several of its smoke-free products, including IQOS devices and General snus, marking significant regulatory advancements for the company.

Sep 19, 2025 07:02:44

Philip Morris International Reaffirms 2025 EPS Growth Forecast

Philip Morris International Inc. is hosting a presentation at the Barclays Global Consumer Staples Conference, where CEO Jacek Olczak will discuss the company's performance and reaffirm its 2025 full-year earnings per share (EPS) forecast. The reported diluted EPS is projected to be between $7.24 and $7.37, reflecting a growth of 13% to 15% compared to 2024. The company attributes this growth to strong sales momentum, particularly in its smoke-free product lines such as IQOS and ZYN, despite facing increased competition in the market.

As of June 30, 2025, smoke-free products accounted for 41% of the company's total net revenues, with over 41 million legal-age consumers using these products globally. PMI has invested over $14 billion since 2008 to develop and market innovative smoke-free alternatives to traditional cigarettes. The company continues to expand its product offerings and aims to transition towards a smoke-free future, with significant growth observed in both international and U.S. markets for its nicotine pouch products.

Sep 02, 2025 09:04:47

Philip Morris International Reports Q2 2025 Financial Results

Philip Morris International Inc. announced its financial results for the second quarter and the first half of 2025, highlighting a reported diluted earnings per share (EPS) growth of 26.6% to $1.95 and an adjusted diluted EPS growth of 20.1% to $1.91. The company raised its full-year guidance due to strong performance in its smoke-free business, which accounted for 41% of total net revenues, reflecting a 15.2% increase in net revenues and a 23.3% rise in gross profit. The IQOS brand continues to show significant growth, with adjusted in-market sales volume increasing by 11.4% and a notable market share gain in Japan and Europe.

In addition to the success of its smoke-free products, Philip Morris reported a 2.1% increase in net revenues from combustibles, driven by strong pricing. The company declared a regular quarterly dividend of $1.35 per share, equating to an annualized $5.40 per share. For the full year, PMI anticipates an adjusted diluted EPS range of $7.24 to $7.37, reflecting a projected increase of 11.5% to 13.5% compared to 2024. The company aims for continued growth in its smoke-free product segments while managing declines in traditional cigarette volumes.

Jul 22, 2025 07:03:11

PMI Announces Investor Focus Event and Regional Performance Insights

Philip Morris International (PMI) hosted an Investor Focus Event on June 24, 2025, highlighting its operations in Europe, which is its largest region by operating income. The company reported a 5-year compound annual growth rate of 7.2% in net revenues, reaching $15.7 billion, with smoke-free products contributing significantly to this growth. PMI's market presence includes 42 countries in Europe, and its smoke-free product IQOS has become a leading brand, generating approximately $6 billion in net revenues for FY’24.

The press release outlined PMI's economic impact in Europe, contributing around €289 billion from 2019 to 2023, including tax revenues that account for about 0.4% of the EU GDP in 2023. The company emphasized its commitment to transitioning towards smoke-free products, aiming for over two-thirds of its net revenues to come from smoke-free offerings by 2030. PMI also discussed its strategic initiatives, including expanding its product portfolio and enhancing brand equity in the smoke-free sector.

Jun 24, 2025 08:10:16

Philip Morris International Declares $1.35 Quarterly Dividend

Philip Morris International Inc. has declared a regular quarterly dividend of $1.35 per common share, which will be payable on July 15, 2025, to shareholders who are on record as of June 27, 2025. The ex-dividend date is also set for June 27, 2025. Investors can find more details on stock and dividends on the company's website.

The company is focused on transitioning to a smoke-free future, with 42% of its first-quarter 2025 total net revenues coming from smoke-free products, which include heat-not-burn and nicotine pouch items. As of December 31, 2024, PMI's smoke-free products were sold in 95 markets and used by approximately 38.6 million adults globally. PMI has invested over $14 billion since 2008 to develop smoke-free alternatives and has received FDA authorizations for various products, highlighting its commitment to innovation in the tobacco sector.

Jun 13, 2025 06:06:09

Philip Morris Reaffirms 2025 EPS Forecast at Investor Conference

Philip Morris International Inc. (PMI) confirmed its 2025 full-year reported diluted earnings per share (EPS) forecast of $7.01 to $7.14 during the dbAccess Global Consumer Conference. This forecast reflects a projected growth of 12% to 14% compared to the previous year, with adjustments for restructuring and currency impacts noted. The company also provided a detailed breakdown of its adjusted diluted EPS, which is expected to range from $7.36 to $7.49, indicating a growth of 10.5% to 12.5% when excluding currency effects.

PMI continues to focus on transitioning to smoke-free products, which accounted for 42% of its total net revenues in the first quarter of 2025. The company has invested over $14 billion since 2008 to develop smoke-free alternatives and has received FDA authorizations for several of its products. PMI aims to evolve its portfolio beyond tobacco and nicotine, indicating a long-term strategy to enhance health-related offerings. The conference presentation is available for live streaming and will be archived for about a year.

Jun 03, 2025 06:01:43

Philip Morris International Holds 2025 Virtual Shareholders Meeting

Philip Morris International Inc. (PMI) conducted its 2025 Annual Meeting of Shareholders, where key executives discussed the company's performance and strategy. CEO Jacek Olczak highlighted the company's rapid advancement in its smoke-free transformation, noting a significant milestone with nearly $15 billion in net revenues from smoke-free products. He emphasized the company's commitment to delivering sustainable growth and returns to shareholders through a multicategory strategy involving brands like IQOS, ZYN, and VEEV.

During the meeting, shareholders voted on several matters, including the election of directors and the approval of executive compensation. Approximately 82 percent of shares were represented, and the results will be detailed in a forthcoming Form 8-K filing with the SEC. PMI's smoke-free products now account for 42% of total net revenues as of the first quarter of 2025, with the company actively working to expand its portfolio beyond traditional tobacco products.

May 07, 2025 09:50:34

Philip Morris Reports Q1 2025 Results and EPS Forecast Increase

Philip Morris International Inc. announced its first-quarter 2025 results, reporting a 24.6% increase in reported diluted earnings per share (EPS) to $1.72, while adjusted diluted EPS grew by 12.7% to $1.69. The company's smoke-free business saw significant growth, contributing 42% to total net revenues, with a 14.4% increase in shipment volumes and a 20.4% rise in net revenues on an organic basis. The company has raised its full-year adjusted diluted EPS forecast, reflecting a positive outlook despite global economic uncertainties.

The company's performance was driven by strong results in both the heated tobacco units (HTU) and oral nicotine pouch segments. In particular, IQOS maintained its position as a leading brand in the heated tobacco category, with market share gains in Japan and Europe. The company declared a quarterly dividend of $1.35 per share. Overall, PMI's total shipment volume increased by 3.9%, with smoke-free volumes up by 14.4%, and net revenues rose by 10.2% on an organic basis.

Apr 23, 2025 07:05:19

Philip Morris International Updates Financial Metrics for 2024

Philip Morris International Inc. announced updates to its financial reporting, reflecting a change in segment reporting following the sale of Vectura Group Ltd. in 2024. The company reported adjusted net revenues for 2024 of $37.9 billion, marking a 7.7% increase from 2023. Smoke-free product revenues grew by 14.2% year-over-year, driven by significant growth in the Americas region. The company also noted a positive performance in Europe, with smoke-free revenues increasing by 9.1% and combustible tobacco revenues showing a 4.0% rise overall.

Conversely, the company experienced declines in certain regions, particularly in the East Asia, Australia & PMI Global Travel Retail segment, where revenues fell by 6.0%. The Americas region also faced a decrease in combustible tobacco revenues by 2.0%. Additionally, the termination of a distribution arrangement in the Middle East resulted in an $80 million reduction in net revenues. Overall, while PMI showed growth in several areas, there were notable challenges in specific markets that impacted overall performance.

Mar 25, 2025 07:13:56

Court Approves Settlement Plan for Tobacco-Related Litigation in Canada

Philip Morris International Inc. announced that its Canadian affiliate, Rothmans, Benson & Hedges Inc. (RBH), has received court approval for a plan to resolve all tobacco product-related claims and litigation in Canada. The approved plan includes a CAD 32.5 billion global settlement, with RBH allowed to retain CAD 750 million in cash. This resolution is expected to enable RBH and its stakeholders to focus on future operations without the burden of ongoing litigation. The plan also includes specific terms for annual payments based on net after-tax income from RBH and its affiliates.

However, the implementation of the plan is contingent upon certain conditions being met, including the exhaustion of appeal rights. Additionally, while the plan aims to provide a resolution to past litigation, PMI acknowledges ongoing risks related to litigation, regulatory changes, and market dynamics that could impact future profitability. The company continues to face challenges in the tobacco market, including health concerns and competition, which may affect its ability to successfully transition to smoke-free products.

Mar 07, 2025 08:05:35